2m 2m 2m 2m 2m 2m 2m
Innate Pharma (IPHYF)
OTC
$1.65-$0.60 (-26.67%)
Price as of May 27, 2026- N/AMarket Cap
- 13.79%1-Year Change
- BiotechnologyIndustry
Innate Pharma (IPHYF)
$1.65-$0.60 (-26.67%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$1.65
$1.65
$1.65
1-Year Range
$1.31
$2.25
$1.65
Latest Close$1.65
Change
-$0.60 (-36.36%)
Volume6,700
Information as of 05/27/2026
Company Profile
INNATE PHARMA
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Biotechnology
INNATE PHARMA
Key Executives
- Jonathan E. Dickinson
- Sonia Quaratino
- Yannis Morel
- Odile Belzunce
- Stephanie Cornen
Current Ownership Distribution
- Other93.9M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)